Ameeta Kharbanda, MD
Critical Care (Intensivists) · Torrance
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Southbay Critical Care A Medical Partnership · 13 clinicians in this group
Looking this up.
Hospitals listed: Providence Little Company of Mary Med Ctr Torrance. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kharbanda’s office at (949) 829-8299 to ask if they take your plan before you enroll.
California Medical Board record
Licence A109134 · Current
Licensed to practise in California · since 2009 · expires 2027-08-31 · University of Poona, Pravara Rural Hospital and Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Providence Little Company of Mary Med Ctr TorranceTorrance, CAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.472, Oct 2024 – Sep 2025
See every measure and the patient survey for Providence Little Company of Mary Med Ctr Torrance
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.472 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.09 (0.11 to 2.07) · 1,022 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.59 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 129.31 (75.73 to 182.88) · 65 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 36 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 70 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.4 · 353 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 361 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 495 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 3,150 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 5,786 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.06 to 0.45) · 5,832 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.21 (2.1 to 6.32) · 1,135 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.81 (0.22 to 3.4) · 375 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.8 to 3.86) · 1,086 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.78 (2.28 to 15.28) · 389 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.58 (1.19 to 7.98) · 377 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2 (0.51 to 3.49) · 247 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 0.93) · 4,918 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 127 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.892 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.225 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.363 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 283 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 709 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 10.5 · 149 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.9 · 428 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -13.8 · 369 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 551 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 59 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 168 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (8.9 to 15.5) · 642 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 331 cases | No different | Jan 2024 – Dec 2024 |
What patients said (414 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$51,897
Medicare paid this office $51,897 for 166 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 105 | $27,995 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $8,725 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $6,756 | $65 |
| Critical care, each additional 30 minutes | 24 | $2,961 | $82 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,502 | $107 |
Who their Medicare patients are
166 Original Medicare patients in 2024. Average age 76 · Under 65 11% · 85 and older 21% · Women 45% · Also on Medicaid 44% · Health risk score 3.19. Above the middle of the specialty; the typical critical care (intensivists) clinician is at 2.58.
Conditions among them: High blood pressure 75% · Diabetes 63% · Heart failure 57% · Chronic kidney disease 52% · Coronary heart disease 48% · Atrial fibrillation 45% · Stroke 42% · COPD 39% · Depression 32% · Dementia 27% · Cancer 17%.
The office billed $199,107, Medicare allowed $66,119 and paid $51,897; for 458 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 166 | 458 | 76 | 3.19 | $199,107 | $51,897 |
| 2023 | 178 | 468 | 76 | 2.95 | $187,861 | $65,854 |
| 2022 | 143 | 411 | 75 | 3.24 | $170,090 | $66,410 |
| 2021 | 120 | 295 | 74 | 2.89 | $99,505 | $47,458 |
| 2020 | 158 | 282 | 76 | 2.79 | $103,384 | $45,101 |
| 2019 | 64 | 126 | 76 | 2.62 | $49,094 | $18,995 |
| 2018 | 339 | 775 | 76 | 2.83 | $421,155 | $121,239 |
| 2017 | 338 | 664 | 75 | 2.96 | $608,544 | $108,060 |
| 2016 | 276 | 648 | 72 | 2.93 | $389,238 | $101,060 |
| 2015 | 187 | 418 | 74 | 3.16 | $218,222 | $68,630 |
| 2014 | 418 | 1,639 | 74 | 3.33 | $593,367 | $209,176 |
| 2013 | 366 | 1,383 | 73 | 2.92 | $534,634 | $186,994 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Critical care, first 30-74 minutes | 135 | $47,640 | $176 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $6,779 | $100 |
| Critical care, each additional 30 minutes | 25 | $3,194 | $89 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 20 | $2,412 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,254 | $66 |
2022: 3 services
| Critical care, first 30-74 minutes | 134 | $59,071 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $2,854 | $86 |
| Critical care, each additional 30 minutes | 13 | $1,379 | $92 |
2021: 2 services
| Critical care, first 30-74 minutes | 105 | $39,461 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $3,118 | $89 |
2020: 2 services
| Critical care, first 30-74 minutes | 113 | $35,338 | $199 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $5,580 | $95 |
2019: 2 services
| Critical care, first 30-74 minutes | 38 | $13,713 | $199 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $3,882 | $95 |
2018: 5 services
| Critical care, first 30-74 minutes | 256 | $99,381 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $12,309 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,205 | $65 |
| Critical care, each additional 30 minutes | 13 | $1,443 | $96 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 20 | $987 | $31 |
2017: 6 services
| Critical care, first 30-74 minutes | 272 | $89,610 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 77 | $9,196 | $92 |
| Critical care, each additional 30 minutes | 19 | $2,130 | $97 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 14 | $1,461 | $104 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 12 | $1,448 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,094 | $64 |
2016: 6 services
| Critical care, first 30-74 minutes | 211 | $79,118 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $10,082 | $92 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 31 | $3,399 | $106 |
| Critical care, each additional 30 minutes | 23 | $2,537 | $98 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 19 | $1,900 | $95 |
| Ultrasonic guidance for blood vessel access | 18 | $230 | $13 |
2015: 4 services
| Critical care, first 30-74 minutes | 157 | $55,304 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $5,404 | $93 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 21 | $2,235 | $106 |
| Critical care, each additional 30 minutes | 19 | $1,965 | $98 |
2014: 6 services
| Critical care, first 30-74 minutes | 189 | $115,178 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 245 | $65,095 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 85 | $14,410 | $164 |
| New patient visit (60+ min) | 22 | $3,653 | $166 |
| Aspiration of initial secretion of lung airway using an endoscope | 14 | $1,609 | $115 |
| Critical care, each additional 30 minutes | 16 | $1,508 | $94 |
2013: 10 services
| Critical care, first 30-74 minutes | 186 | $121,460 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 150 | $29,478 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 111 | $18,960 | $158 |
| New patient visit (60+ min) | 23 | $3,780 | $164 |
| Aspiration of initial secretion of lung airway using an endoscope | 17 | $2,851 | $130 |
| Return visit (30+ min) | 18 | $1,653 | $87 |
| Long return visit (40+ min) | 13 | $1,626 | $116 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 13 | $1,233 | $95 |
| Critical care, each additional 30 minutes | 11 | $956 | $87 |
| Insertion of artery tube for blood sampling or infusion through skin | 12 | $478 | $40 |
Medicaid work
$15,287 in 2023
Medicaid paid $15,287 for 177 billed services this clinician did in 2023, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 177 | $15,287 |
| 2023 | 177 | 1 | 15 | $15,287 |
| 2022 | 88 | 1 | 13 | $7,246 |
| 2021 | 171 | 1 | 15 | $17,959 |
| 2020 | 81 | 1 | 25 | $6,000 |
See the largest Medicaid services in earlier years
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 88 | $7,246 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 171 | $17,959 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 81 | $6,000 |
Money from drug and device companies
$22 in 2024
| 2024 | 1 | 1 | None | $22 |
| 2023 | 1 | 1 | None | $150 |
| 2022 | 1 | 1 | None | $144 |
| 2021 | 1 | 1 | None | $95 |
| 2019 | 3 | 3 | None | $289 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abiomed | Impella | $22 | 1 payment
|
See the published payment
| Abiomed | Gift · 2024-11-08 | Impella | $22 |
See earlier years (2023, 2022, 2021, 2019)
2023: $150
| Abiomed | Impella | $150 | 1 payment
|
2022: $144
| Abiomed | Impella | $144 | 1 payment
|
2021: $95
| Abiomed | Impella | $95 | 1 payment
|
2019: $289
| Stryker | Trevo | $140 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $123 | 1 payment
|
| Actelion Pharmaceuticals US | Opsumit | $26 | 1 payment
|
Professional record
- NPI
- 1568616365
- Licence
- CA A109134California A109134: Current · expires 2027-08-31
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- Po Box 356, Cupertino, CA, 95015
- NPI first listed
- 2008-11-06
- NPI last updated
- 2017-03-30
This is when the NPI record was last certified, not a medical board exam.